首页 > 抗体蛋白 > 抗体
FITC anti-mouse Ly-6A/E (Sca-1) Antibody
产品名称:
FITC anti-mouse Ly-6A/E (Sca-1) Antibody
产品类别:
抗体
产品编号:
108105
产品应用:
108105
[价格]
规格 价格 库存
50µg ¥ 994 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-2-dependent mouse T-cell line (CTL-L)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The D7 antibody has been reported to induce T cell activation and inhibit TCR-induced IL-2 production. Additional reported applications (for the relevant formats) include: Western blotting1,2, immunoprecipitation1, in vitro lymphocyte activation3-6, induction of redirected lysis7, induction of T cell inhibitory signalling8, immunofluorescence9, and immunohistochemical staining of acetone-fixed frozen sections13 and Bouin-fixed,?paraffin-embedded samples9.

The two Sca-1 recognizing clones?D7?and E13-161.7 have been shown to bind distinct epitopes due to the inability of D7 to block the binding of E13-161.7.14?

Application References

(PubMed link indicates BioLegend citation)
  1. Ortega G, et al. 1986. J. Immunol. 137:3240. (WB, IP)
  2. Palfree RGE, et al. 1986. Immunogenetics 23:197. (WB)
  3. Codias EK, et al. 1990. J. Immunol. 144:2197.
  4. Malek TR, et al. 1986. J. Exp. Med. 164:709.
  5. Codias EK, et al. 1990. J. Immunol. 145:1407.
  6. Ivanov V, et al. 1994. J. Immunol. 153:2394.
  7. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  8. Fleming T, et al. 1994. J. Immunol. 153:1955.
  9. van Bragt MPA, et al. 2005. Biol. Reprod. 73:634. (IF, IHC)
  10. Umland O, et al. 2007. J. Immunol. 178:4147.
  11. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 45:149. (FC) PubMed
  12. Pronk CJ, et al. 2011. J. Exp Med. PubMed
  13. English A, et al. 2000. J. Immunol. 165:3763. (IHC)
  14. Bamezai A and Rock KL. 1995. Proc. Natl. Acad. Sci. USA 92:4294.
  15. Wiesner DL, et al. 2015. PLoS Pathog. 11:1004701. PubMed
Product Citations
  1. Ludwik KA, et al. 2020. Cell Reports. 32(3):107931. PubMed
  2. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  3. Yamaguchi A, et al. 2021. Genes Cells. 26:782. PubMed
  4. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  5. Cha S, et al. 2021. Int J Mol Sci. 22:. PubMed
  6. Mittal S, et al. 2016. Stem Cell Reports. 7:583-590. PubMed
  7. Hughes RM, et al. 2020. Cancer Research. 79(14):3636-3650.. PubMed
  8. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  9. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  10. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  11. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  12. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  13. Lima-Junior DS, et al. 2021. Cell. . PubMed
  14. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  15. Kim JH, et al. 2021. J Cachexia Sarcopenia Muscle. 12:177. PubMed
  16. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  17. Kim J, et al. 2016. Nat Cell Biol. 18:930-940. PubMed
  18. Zheng X, et al. 2015. Cell Rep. 13:1505-1518. PubMed
  19. Kanemaru K, et al. 2015. PLoS One. 10: 0144436. PubMed
  20. Ghosh D, et al. 2016. J Immunol. 197: 1788 - 1800. PubMed
  21. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  22. Baja?a S, et al. 2022. iScience. 25:103732. PubMed
  23. Koide S, et al. 2022. iScience. 25:103603. PubMed
  24. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  25. Wilkinson AC, et al. 2019. Nature. 571:117. PubMed
  26. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  27. Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed
  28. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  29. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
RRID
AB_313342 (BioLegend Cat. No. 108105) AB_313343 (BioLegend Cat. No. 108106)

Antigen Details

Structure
Ly-6 multigene family, 18 kD
Distribution

Hematopoietic stem cells, activated T cells and B cells, subset of resting B cells and T cells

Function
Regulates B and T cell responses
Cell Type
B cells, Hematopoietic stem and progenitors, Mesenchymal Stem Cells, T cells
Biology Area
Immunology, Stem Cells
Antigen References

1. Rock KL, et al. 1989. Immunol. Rev. 111:195.
2. Morrison SJ, et al. 1994. Immunity 1:661.
3. Spangrude GJ, et al. 1988. J. Immunol. 141:3697.
4. Malek T, et al. 1986. J. Exp. Med. 164:709.

Gene ID
110454 View all products for this Gene ID
UniProt
View information about Ly-6A/E on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线